Our investigation also revealed that other isoforms of phosphofructokinase, i.e., PFKL and PFKM, do not play important roles in promoting breast cancer progression as only high PFKP gene expression is associated with poor survival in breast cancer patients. This evidence concerns the gene PFKL and breast cancer.